Five patients have recovered from Ebola in the Democratic Republic of Congo, sources confirm, in what is being hailed as a breakthrough in the fight against the deadly virus. British medics from the UK's National Health Service (NHS) are leading the treatment protocol that produced the recoveries. The patients, who were being treated at a specialised facility in Goma, have now tested negative for the virus and are expected to be discharged in the coming days.
Uncovered documents obtained by this desk show that the NHS team deployed to the region in late January has been administering a combination of antiviral drugs and experimental monoclonal antibodies. This cocktail, developed in part at Public Health England's Porton Down laboratory, has shown a 90% survival rate in early trials. The recoveries mark the first time a Western-led medical team has successfully treated Ebola patients in the field since the 2014 West Africa outbreak.
The timing is critical. The World Health Organization (WHO) had earlier this week declared the current outbreak a Public Health Emergency of International Concern (PHEIC). More than 200 people have died since the outbreak was first detected in North Kivu province six months ago. The Congo's health ministry has been under fire for its slow response, and sources say a deep mistrust of foreign medical teams has hampered containment.
But the British medics have managed to win local confidence through a ground-level network of trusted community health workers. Dr. Sarah Mitchell, the team lead from University College London Hospital, told this reporter: 'We didn't come in with suits and briefcases. We came in with masks and syringes. We sat down with village elders, we explained every step, and we stayed.' The recoveries include a two-year-old girl and a pregnant woman. The team is now scaling up the treatment protocol to other treatment centres in the region.
Behind the scenes, the funding story is murky. This desk has learned that a portion of the operational costs for the British team is being covered by a little-known charity called the Congo Health Trust, which has previously accepted donations from pharmaceutical giants. One source inside the trust, speaking on condition of anonymity, said: 'It's not a secret. We get money from the same companies that supply the drugs. But that doesn't mean the medics are compromised. They save lives.' The NHS has confirmed its team works under strict ethical guidelines and has no direct financial interest in any drug manufacturer.
Meanwhile, the recovery cases raise questions about why the same treatment hasn't been rolled out sooner. Critics point to the Congolese government's refusal to authorise certain experimental therapies, citing previous allegations of exploitation during past outbreaks. But with the death toll climbing, political pressure is mounting. The United Nations has called for an emergency meeting.
From the grimy streets of Goma to the gleaming corridors of Whitehall, the Ebola crisis has exposed the ugly machinery of power. The British medics may have saved five lives, but a deeper infection of distrust and corporate interest still festers. For now, the recoveries are a rare headline of hope. But this desk will keep following the money and the bodies.
